Small-bowel permeability in collagenous colitis

Abstract

Objective. Collagenous colitis (CC) is a chronic inflammatory bowel disease that affects the colon. However, some patients with CC present with accompanying pathologic small-bowel manifestations such as coeliac disease, defects in bile acid absorption and histopathologic changes in small-intestinal biopsies, indicating that CC is a pan-intestinal disease. In small-intestinal disease, the intestinal barrier function may be impaired, and the permeability of the small intestine altered. The purpose of this research was to study small-bowel function in patients with CC as expressed by intestinal permeability. Material andmethods. Ten patients with CC and chronic diarrhoea participated in the study. Coeliac disease was excluded by small-bowel biopsy and/or serology. Intestinal permeability was assessed as urinary excretion (ratios) 2, 4 and 6 h after ingestion of ¹⁴C-labelled mannitol (¹⁴C-mannitol) and ^99mTc-labelled diethylenetriamine-pentaacetic acid (^99mTc-DTPA). Data were compared with the results from healthy controls. Results. No difference was found between groups in urinary excretion of ¹⁴C-mannitol and ^99mTc-DTPA after 2, 4 or 6 h, respectively. Likewise, no significant differences in the ^99mTc-DTPA/¹⁴C-mannitol ratios between patients and controls were detected after 2 h: 0.030 (0.008–0.130) versus 0.020 (0.007–0.030), p=0.19, after 4 h: 0.040 (0.009–0.180) versus 0.020 (0.008–0.040), p=0.14 or after 6 h: 0.040 (0.012–0.180) versus 0.020 (0.010–0.040), p=0.17. Conclusions. No alterations in intestinal permeability in patients with CC could be demonstrated. Impairment of the integrity of the mucosa of the small bowel and the presence of a general dysfunction of the small intestine in patients with CC seem unlikely.

• Collagenous colitis
• intestinal permeability
• mannitol
• 99mTc-labelled diethylenediamine-pentaacetic acid